Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients.
Dong Yeon KimSung Woo ChoKyu Tae ParkJong-Hwa AhnTaek Kyu ParkYong Ho JangKi Hong ChoiJoo-Myung LeeJeong Hoon YangYoung Bin SongJin Ho ChoiSeung-Hyuk ChoiHyeon Cheol GwonSang Hoon LeeJoo-Yong HahnPublished in: Journal of Korean medical science (2021)
Compared with prolonged DAPT, clopidogrel monotherapy showed similar long-term outcomes in patients at high-risk after second-generation DES implantation.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- end stage renal disease
- st segment elevation myocardial infarction
- acute myocardial infarction
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- peritoneal dialysis
- prognostic factors
- coronary artery bypass grafting
- heart failure
- combination therapy
- atrial fibrillation
- clinical trial
- patient reported